Homeostasis and food craving in obesity: a functional MRI study
Taylor & Francis, Boca Raton, pp 391399 Dringen R, Kranich O, Hamprecht B (1997) The -glutamyl transpeptidase inhibitor acivicin preserves glutathione released by astroglial cells in culture
B Sun et al
Strategically, India can both expand device capacity and lead in oral GLP-1 manufacturing, easing supply constraints and improving access. The localisation of device production could enable quicker market response time by reducing dependence on imported components
Clinical trials show that most patients achieve meaningful weight reduction between 1.0 mg and 2.4 mg weekly, though individual responses vary significantly based on genetics, metabolism, and lifestyle factors
Scientific References GLP-1 receptor agonists: reminder of the potential side effects and to be aware of the potential for misuse